Veterans health administration leads the way in population mental health science: Commentary on Dodge et al. (2024).

Recently, Dodge et al. (2024) published an article in offering recommendations to the mental health field for changing from an individual-level to a population-level focus. These recommendations included scaling up evidence-based programs, innovating and evaluating population-level interventions, and creating a primary system of care to promote mental health and well-being.

PDSS1 mutations-associated steroid-resistant nephrotic syndrome: case report and review of literature.

PDSS1 mutations hamper Coenzyme Q10 biosynthesis and cause a rare multisystem mitochondrial disease characterized by diverse clinical features and limited treatment options. To date, renal involvement has been reported in only one patient. We report a new female patient with compound heterozygous PDSS1 mutations and the clinical outcome following a trial of Coenzyme Q10 therapy.

Effectiveness of A Culturally Adapted Family Model of Diabetes Self-Management Education and Support among Marshallese Pacific Islanders Delivered in a Group Format in Churches.

Introduction: Diabetes self-management education and support (DSMES) is effective for reducing health complications among people with type 2 diabetes (PWD). However, standard DSMES interventions have not been effective for Marshallese Pacific Islanders.

Methods: A culturally adapted Family-DSMES intervention for Marshallese PWD was implemented in churches in Hawaii and Washington state and delivered by Marshal-lese community health workers.

B7-H3 is widely expressed in soft tissue sarcomas.

Purpose: Targeted therapy development in soft tissue sarcoma (STS) has been burdened by the heterogeneity of this group of rare tumors. B7 homolog 3 protein (B7-H3) is a molecule in the same family as programmed death-ligand 1 (PD-L1). It has limited expression in noncancerous tissues and is overexpressed in many cancers, making it an attractive target for cancer therapy, and clinical trials targeting B7-H3 are actively underway.